Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection
about
Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenThe murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy.Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat.A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in miceHLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgeniA Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensImmunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex VaccineVaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infectionA Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.New concepts in herpes simplex virus vaccine development: notes from the battlefield.CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And Characterization.Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.Evaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice.
P2860
Q30496837-CD5CAD59-211E-46C1-AA6D-C46E76EBEAF4Q33663463-116C66B4-89E9-462D-8BC0-07611299B0F0Q33856067-FDB00B6D-DF48-457B-9AF0-1041544F737AQ33885018-E9391F8E-6B17-4212-A133-834BEC04FBF4Q34162920-65A89E5A-2B39-4153-804B-15E4C57DCE80Q35009410-ABAD32E6-92A7-45C5-B643-92978ED5CB8BQ35122383-26C48168-53E9-4D5D-A7D0-6EF8DA5EAF83Q35914367-9ECBDFAC-7179-43DE-B427-11BA94395BD7Q35920203-5FBC109A-7205-46D7-8547-2B2505D0CBA4Q36025675-16974B8C-8067-47E1-B3F1-9354E0BB07D7Q37127506-4D1BBF41-7E6E-4E59-9E6E-C806A90C11CAQ37253436-405C3EEB-FCF8-4829-8B3C-149D1EFB1715Q37384857-354C6416-451A-43CC-B089-33ED77E58E78Q37679220-0A2239FA-6F2C-4FA9-B38C-A31C9FB77264Q37963480-2A59AA56-982E-487D-B8E3-54DB59DE3582Q40067153-2990B37D-304A-4870-9575-43650554309CQ40121437-E66E4A2E-6E88-43A8-9B7E-DAABAD096296Q40257387-ECF50A1F-B6BF-4647-B598-30821B96E182
P2860
Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Herpes simplex virus type 2 te ...... DNA immunization and infection
@en
Herpes simplex virus type 2 te ...... NA immunization and infection.
@nl
type
label
Herpes simplex virus type 2 te ...... DNA immunization and infection
@en
Herpes simplex virus type 2 te ...... NA immunization and infection.
@nl
prefLabel
Herpes simplex virus type 2 te ...... DNA immunization and infection
@en
Herpes simplex virus type 2 te ...... NA immunization and infection.
@nl
P2093
P2860
P356
P1476
Herpes simplex virus type 2 te ...... DNA immunization and infection
@en
P2093
Adrian Vilalta
Benjamin Byrd
Christopher L McClurkan
David Kaslow
John Sidney
Kai M Wilhelm
Lichun Dong
Michal Margalith
William J Muller
P2860
P304
P356
10.1099/VIR.0.008771-0
P407
P577
2009-03-04T00:00:00Z